Blogs
Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.
  • Semagcare - Semaglutide Tablets Distributor & FDF Development

    2024-07-15

    Unibest proudly partners with a renowned supplier to bring you Semagcare, a premium product line featuring in-housed developed Semaglutide API and Semaglutide tablets available in 3mg, 7mg, and 14mg dosages.Key FeaturesSemagcare: High-quality Semaglutide tablets intended for diabetes and obesity tre Read More
  • Avacopan - Orphan Drug with a Growing Market

    2024-06-07

    Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA-associated vasculitis) is a rare but serious autoimmune disease affecting small blood vessels. With a global prevalence estimated between 30-218 cases per million, it leads to inflammation of blood vessels and potential organ damage. C Read More
  • Drug Briefing: Avacopan

    2024-05-10

    Query Drug:AvacopanQuery Time:2024-06-04 09:21:05*** Disclaimer *** The information provided here is sourced from resources such as Drugs.com, the Orange Book, etc., and is auto-generated by the Unibest Digital Center. The content is intended exclusively for pharmaceutical professionals. Unibest doe Read More
  • Drug Briefing: Ruxolitinib

    2024-04-25

    Query Drug:RuxolitinibQuery Time:2024-04-25 09:12:38*** Disclaimer *** The information provided here is sourced from resources such as Drugs.com, the Orange Book, etc., and is auto-generated by the Unibest Digital Center. The content is intended exclusively for pharmaceutical professionals. Unibest Read More
  • Drug Briefing: Belzutifan

    2024-04-11

    Query Drug:BelzutifanQuery Time:2024-04-11 13:18:28 Read More
  • Drug Briefing: Midazolam

    2024-04-11

    Query Drug:Midazolam Query Time:2024-04-17 10:20:21 Read More
  • Trilaciclib, The First-in-Class Myeoprotection: Market, Advantages, and Competitions

    2023-09-15

    In recent years, the concept of myeloprotection—protecting bone marrow from the damaging effects of chemotherapy—has emerged as a crucial component in cancer therapy. In the face of this evolving landscape, G1 Therapeutics' trilaciclib (marketed as COSELA®) stands out. Trilaciclib is the first thera Read More
  • Pralsetinib and NSCLC

    2023-09-14

    Compounds with CAS RN 2097133-17-8, CAS RN 2778223-52-0 and CAS RN 35277-02-2 can be used to synthesize Read More
  • Advancements in Pralsetinib Production: The New Intermediates on The Block

    2023-09-04

    IntroductionPralsetinib, an innovative cancer-fighting drug, has been making significant strides in targeted oncology therapy—specifically against non-small cell lung cancer (NSCLC) with RET gene alterations. Pralsetinib's remarkable efficacy and ability to provide targeted treatment for cancer make Read More
  • Total 2 pages  Go to Page
  • Go